Innovative Eyewear CFO receives 60,000-share award

Q: How many shares did LUCY CFO Gayle Oswald receive?

Gayle Oswald received a direct award of 60,000 common shares on October 29, 2026, at $0.0000 per share. Her reported direct holdings following the award were 79,798 shares.

The 60,000-share award vests in eight equal semi-annual installments from April 2, 2027, through August 19, 2030.

Available on EDGAR 11/02/2026 - 04:06 PM EST Accepted by SEC EDGAR 11/02/2026 - 04:06 PM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

On October 29, 2026, Innovative Eyewear Inc (LUCY) Chief Financial Officer Gayle Oswald received a direct award of 60,000 common shares at $0.0000 per share. The shares vest in eight equal semi-annual installments of 7,500, on April 2 and August 19 of each year from 2027 through 2030. Her reported direct holdings after the award were 79,798 shares.

Insider Trade Summary

Grant/Award: 60,000 shares

Grant/Award 1 txn

Insider Gayle Oswald

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock ^F1	60,000	$0.00	$0.00

Holdings After Transaction: Common Stock — 79,798 shares (Direct)

Holdings Before and After: Common Stock, 19,798 to 79,798 shares (Direct)

Footnotes (1)

F1. The securities reported vest in eight equal semi-annual installments of 7,500 on: 04/02/2027, 08/19/2027, 04/02/2028, 08/19/2028, 04/02/2029, 08/19/2029, 04/02/2030, and 08/19/2030.

Key Figures

Common shares awarded: 60,000 shares Transaction price per share: $0.0000 per share Direct holdings after award: 79,798 shares +2 more

5 metrics

Common shares awarded 60,000 shares Award reported October 29, 2026

Transaction price per share $0.0000 per share Award reported October 29, 2026

Direct holdings after award 79,798 shares Reported following the award

Vesting installment 7,500 shares Each equal semi-annual installment

Vesting installments 8 installments Semi-annual installments scheduled from April 2, 2027, through August 19, 2030

Key Terms

vests, semi-annual installments

2 terms

vests financial

"securities reported vest in eight equal"

semi-annual installments financial

"eight equal semi-annual installments of 7,500"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did LUCY CFO Gayle Oswald receive?

Gayle Oswald received a direct award of 60,000 common shares on October 29, 2026, at $0.0000 per share. Her reported direct holdings following the award were 79,798 shares.

What is the vesting schedule for Gayle Oswald's LUCY stock award?

The 60,000 shares vest in eight equal semi-annual installments on April 2, 2027; August 19, 2027; April 2, 2028; August 19, 2028; April 2, 2029; August 19, 2029; April 2, 2030; and August 19, 2030.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gayle Oswald

(Last)

(First)

(Middle)

C/O INNOVATIVE EYEWEAR INC.

11900 BISCAYNE BLVD., SUITE 630

(Street)

MIAMI

FLORIDA

33181

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
10/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	10/29/2026		A		60,000⁽¹⁾	A	$0.00	79,798	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The securities reported vest in eight equal semi-annual installments of 7,500 on: 04/02/2027, 08/19/2027, 04/02/2028, 08/19/2028, 04/02/2029, 08/19/2029, 04/02/2030, and 08/19/2030.

	/s/ Oswald Gayle	11/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR